Khalil Zaman

10PUBLICATIONS
124CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHealth counsellingTumour immunologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

|Feb 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Oct 30, 2025
[Breast cancer screening in Switzerland : organised, opportunistic, or opting out ?]

Romain Freund, Rami Hajri, Murielle Bochud

|Oct 08, 2025
Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial.

Shanu Modi, William Jacot, Hiroji Iwata

|Apr 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.

Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope

|Jan 08, 2023
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.

Carole Bandiera, Isabella Locatelli, Perrine Courlet

Pageof 2

Frequent Collaborators

4 joint publications

Athina Stravodimou

3 joint publications

Chantal Csajka

3 joint publications

Carole Bandiera

3 joint publications

Apostolos Sarivalasis